SEC Form 4 · accession 0001814876-26-000025

Royalty Pharma plc · RPRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Terrance P. Coyne

Officer — EVP & CFO

Period of report

Aug 5, 2026

Accepted (ET)

Aug 7, 2026 · 5:24 pm EDT

Rule 10b5-1 plan

box not checked

Issuer CIK

0001802768

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Class A Ordinary Shares^F1	Aug 5, 2026	A	11,002	$0.00	A	11,002	I	TPC RP EPA1 LLC
Class A Ordinary Shares	holding	—	—		—	24,170	I	By Spouse's IRA
Class A Ordinary Shares	holding	—	—		—	23,270	I	By IRA
Class A Ordinary Shares	holding	—	—		—	1,500	D
Class A Ordinary Shares	holding	—	—		—	1,450	I	By Spouse

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Class E Ordinary Shares^F2	—	Aug 7, 2026	G	18,500	D	—	—	Class A Ordinary Shares	18,500	1,788,777	I

Explanation of responses

F1Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.
F2No Class E Ordinary Shares of RPH ("Class E Shares") are being converted by the Reporting Person. Class E Shares are subject to vesting conditions. Once vested, the Class E Shares may be converted at any time into an equivalent number of Class B ordinary shares of RPH ("Class B Shares") on a one-for-one basis, and there is no expiration date for such conversion. Each Class B Share may be converted at any time into an equivalent number of Class A ordinary shares of the Issuer on a one-for-one basis and there is no expiration date for such conversion.

Remarks

In addition to the Class A Ordinary Shares disclosed above, the Reporting Person and family vehicles controlled by the Reporting Person hold limited partnership interests in RPI US Partners 2019, LP exchangeable into 6,448,180 Class A Ordinary Shares.